Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) has a significant clinical relevance of being associated with a shorter median time to relapse and death and does not respond to endocrine therapy or other available targeted agents. Increased aggressiveness of this tumor, as well as resistance to standard drug t...

Descripción completa

Detalles Bibliográficos
Autores principales: Collina, Francesca, Di Bonito, Maurizio, Li Bergolis, Valeria, De Laurentiis, Michelino, Vitagliano, Carlo, Cerrone, Margherita, Nuzzo, Francesco, Cantile, Monica, Botti, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609334/
https://www.ncbi.nlm.nih.gov/pubmed/26504780
http://dx.doi.org/10.1155/2015/158682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609334/
https://www.ncbi.nlm.nih.gov/pubmed/26504780
http://dx.doi.org/10.1155/2015/158682

Ejemplares similares